NuWave Investment Management’s United Therapeutics UTHR Stock Holding History

NuWave Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-293	Closed	-$53K	–	355
2022 Q1	$53K	Buy	+293	New	+$55.8K	0.07%	222
2021 Q4	–	Sell	-552	Closed	-$102K	–	423
2021 Q3	$102K	Sell	552 -1,197	-68%	-$236K	0.12%	199
2021 Q2	$314K	Buy	+1,749	New	+$333K	0.35%	94
2020 Q4	–	Sell	-1,755	Closed	-$177K	–	527
2020 Q3	$177K	Buy	1,755 +1,598	+1,018%	+$175K	0.27%	122
2020 Q2	$19K	Buy	+157	New	+$17.7K	0.03%	277
2020 Q1	–	Sell	-99	Closed	-$9K	–	405
2019 Q4	$9K	Hold	99	–	–	0.01%	349
2019 Q3	$8K	Sell	99 -2,759	-97%	-$222K	0.01%	366
2019 Q2	$223K	Buy	2,858 +2,854	+71,350%	+$267K	0.23%	129
2019 Q1	$0	Sell	4 -3	-43%	-$350	﹤0.01%	428
2018 Q4	$1K	Hold	7	–	–	﹤0.01%	390
2018 Q3	$1K	Hold	7	–	–	﹤0.01%	387
2018 Q2	$1K	Sell	7 -1,050	-99%	-$115K	﹤0.01%	365
2018 Q1	$116K	Buy	1,057 +1,049	+13,113%	+$133K	0.18%	150
2017 Q4	$1K	Buy	+8	New	+$1.02K	﹤0.01%	346

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NuWave Investment Management's UTHR Position: Q2 2022 in Review

NuWave Investment Management sold out of United Therapeutics (UTHR) in Q2 2022, closing a stake of 293 shares — an estimated $53K sold.

NuWave Investment Management first reported a position in UTHR in Q4 2017 and held it in 14 quarters. The position peaked at $314K in Q2 2021. 473 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.

NuWave Investment Management reported no remaining United Therapeutics position as of Q2 2022 after selling out during the quarter.
NuWave Investment Management sold 293 United Therapeutics shares in Q2 2022, an estimated $53K.
NuWave Investment Management first reported a position in United Therapeutics in Q4 2017 and held it in 14 quarters.
NuWave Investment Management's United Therapeutics position peaked at $314K in Q2 2021.
473 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.

Based on NuWave Investment Management's 13F filing for Q2 2022, filed 8 Jul 2022.